TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
BLFS

BioLife Solutions Inc

Healthcare · Medical Instruments & Supplies

37.70$ -0.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

BioLife Solutions Inc (BLFS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 447 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BLFS
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
11 7.9 8.6 8.5 8.9 12 12 22 46 45 48 52 84 93 95 114 196 235 240 521 559 554 544 470 488 450 446 433 411 413 402 375 382 399 395 387 392 406 401 447
5.0 4.6 5.6 5.7 6.4 9.9 10 19 38 38 39 29 32 24 26 46 128 115 117 127 131 126 119 118 136 138 133 120 117 121 112 88 89 149 131 125 127 137 133 135
1.4 1.4 2.3 2.3 2.8 6.7 7.0 14 32 31 32 20 21 6.4 6.4 30 94 90 89 76 75 70 59 24 27 19 19 21 19 28 30 22 24 95 67 32 29 33 23 24
1.4 1.4 2.3 2.3 2.8 6.7 7.0 14 32 31 32 20 21 6.4 6.4 30 94 90 89 76 75 70 59 47 62 63 55 46 41 44 45 34 34 105 89 82 79 89 81 82
1.3 1.2 1.1 1.2 1.4 1.0 1.0 2.2 2.7 3.0 2.9 3.8 4.3 5.3 8.2 4.4 6.1 8.0 11 21 20 23 24 31 32 34 30 27 25 19 19 18 18 9.2 9.2 10 11 8.0 13 11
1.9 1.8 1.8 1.8 1.9 1.8 1.8 2.1 2.9 3.5 4.1 5.3 5.7 11 11 11 11 12 12 26 30 28 30 33 34 35 41 39 43 43 43 32 32 29 28 28 28 30 33 36
3.5 1.2 1.1 1.2 1.1 1.1 1.1 1.0 1.3 1.3 1.4 1.3 2.1 5.6 5.4 5.3 5.3 25 11 43 17 47 18 19 22 – 26 26 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – 9.5 28 34 34 34 34 58 58 196 224 225 225 225 225 225 225 225 225 225 225 225 225 212 212 212 212 209 209 209
4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – 4.4 16 22 21 21 20 31 30 149 155 152 149 77 74 32 31 29 22 21 20 19 18 9.6 8.9 8.1 7.5 4.3 3.9 3.7
4.2 4.8 5.8 1.7 1.7 2.1 1.8 2.1 2.5 2.3 3.7 5.5 7.3 49 27 8.1 9.0 30 31 69 70 76 65 58 79 86 88 81 79 75 68 54 56 51 43 40 38 34 29 27
3.5 1.1 1.1 1.0 1.1 1.5 1.3 1.7 2.1 1.9 2.7 3.1 4.9 7.7 25 7.5 8.4 16 16 31 36 43 35 33 37 45 47 40 43 42 39 31 32 33 28 28 27 23 18 14
1.8 2.8 3.9 – – – – – – – 0.7 0.7 0.8 – 0.8 0.8 0.7 1.7 2.9 11 9.5 3.8 3.5 7.1 7.9 4.8 4.3 5.3 8.3 7.6 12 13 15 12 12 12 9.7 7.2 4.8 2.6
1.1 0.7 0.6 0.5 0.4 0.7 0.6 0.8 1.1 0.7 1.3 0.9 1.6 6.5 3.5 3.1 2.4 3.7 4.3 9.8 14 15 12 12 13 15 16 11 12 6.9 5.0 4.2 3.8 3.6 3.3 3.2 2.9 1.5 3.8 2.5
0.0 2.8 3.9 0.0 0.0 0.0 0.0 0.0 0.0 – 1.0 – – – – – – 0.7 0.9 5.0 6.1 6.4 6.3 6.2 24 24 24 24 21 18 16 10 7.8 5.0 2.5 – – – – –
6.2 3.2 2.8 6.8 7.2 10 10 20 44 15 44 46 77 43 68 106 187 205 209 452 489 478 479 412 408 364 358 352 332 338 333 321 325 349 353 347 354 372 372 420
-68 -71 -72 -73 -73 -74 -74 -73 -72 -98 -71 -70 -60 -100 -78 -94 -95 -97 -99 -91 -91 -107 -112 -185 -195 -247 -261 -271 -300 -313 -325 -346 -348 -335 -336 -351 -351 -340 -339 -293
13 13 13 13 13 14 14 20 24 24 19 25 25 23 21 23 32 33 33 40 43 42 42 42 43 43 43 43 44 44 45 46 46 48 47 48 49 49 49 49

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?